Nir Salomon
Nir Salomon (born 1978) (Hebrew: ניר סלומון) is an integrative gastroenterology specialist, researcher, co-founder & Chief of R&D at Evinature, and founder and director of Sheba Hospital’s Integrative Gastroenterology Unit[1].
Salomon was born in Boston and raised in Jerusalem. He is best known for leading research programs for the development of neutraceutical treatments for ulcerative colitis, namely CurQD.[2]
Clinical and medical fields of interest
After completing his studies in Traditional Chinese medicine (TCM) in Israel he studied under Prof. Liang Chao, head of the gastroenterology department at the Chengdu University Hospital of TCM.
Salomon went on to establish the Integrative Gastroenterology unit at Sheba Medical Center, collaborating with Professor Shomron Ben-Horin on a research project for ten years to develop nutraceutical therapies for Inflammatory Bowel Disease[3]. They conducted clinical trials from 2011 to 2022 on the use of CurQD, a combination of curcumin and Qing Dai, on patients with UC.[2][4]
Salomon presented his international, investigator-initiated placebo-controlled trial on CurQD at the Crohn’s and Colitis Foundation of America (CCFA), where it won the Poster of Distinction award.[5]
Evinature
In 2021, Salomon and Ben-Horin founded Evinature to provide therapies for IBD patients[6]. Salomon currently lectures at medical conferences, promoting integrative therapies.
Publications
- Lang, A., Salomon, N., Ben-Horin, S., et al. (2015), "Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial". Clinical Gastroenterology and Hepatology.[7]
- Yanai H, Salomon N, Lahat A. (2016) "Complementary Therapies in Inflammatory Bowel Diseases. Curr Gastroenterol Rep.[8]
- Yanai H, Salomon N, Ben-Horin S, Kopylov U. (2023) "Real-world experience with Curcumin-QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study." Aliment Pharmacol Ther.[9]
- Ben-Horin S, Salomon N, Kopylov U., et al. (2023) "Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial." Clin Gastroenterol Hepatoly.[10]
References
- ↑ "SHEBA STUDY OFFERS BREAKTHROUGH IN PLANT-BASED ULCERATIVE COLITIS TREATMENT". sheba-global.com (Press release). February 14, 2023.
- ↑ 2.0 2.1 "Israel: Sheba Medical Center touts plant-based treatment for Ulcerative Colitis". i24NEWS.
- ↑ "Evinature's Co-Founder Nir Salomon Hits the Road for 2023's Lecture Tour in USA's Leading Medical Centers To Discuss Scientific Based IBD Treatments". BioPharma Dive (Press release).
- ↑ "Curcumin-QingDai induces remission in active UC, 'paves the way' for integration in care". www.healio.com.
- ↑ "Herbal combination tames active UC in small study". www.mdedge.com.
- ↑ "Ulcerative colitis: Curcumin, QingDai combo may aid treatment". www.medicalnewstoday.com. February 2, 2023.
- ↑ A, Lang; N, Salomon; Jc, Wu; U, Kopylov; A, Lahat; O, Har-Noy; Jy, Ching; Pk, Cheong; B, Avidan; D, Gamus; I, Kaimakliotis; R, Eliakim; Sc, Ng; S, Ben-Horin (August 2, 2015). "Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial". Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 13 (8). doi:10.1016/j.cgh.2015.02.019. PMID 25724700 – via pubmed.ncbi.nlm.nih.gov.
- ↑ Yanai, Henit; Salomon, Nir; Lahat, Adi (December 2, 2016). "Complementary Therapies in Inflammatory Bowel Diseases". Current Gastroenterology Reports. 18 (12): 62. doi:10.1007/s11894-016-0537-6. PMID 27747459 – via PubMed.
- ↑ Yanai, Henit; Salomon, Nir; Lahat, Adi; Ungar, Bella; Eliakim, Rami; Kriger-Sharabi, Ofra; Reiss-Mintz, Hilla; Koslowsky, Benjamin; Shitrit, Ariella Bar-Gil; Tamir-Degabli, Natalie; Dotan, Iris; Zittan, Eran; Maharshak, Nitsan; Hirsch, Ayal; Ben-Horin, Shomron; Kopylov, Uri (July 2, 2023). "Real-world experience with Curcumin-QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study". Alimentary Pharmacology & Therapeutics. 58 (2): 175–181. doi:10.1111/apt.17538. PMID 37157131 Check
|pmid=value (help) – via PubMed. - ↑ Ben-Horin, Shomron; Salomon, Nir; Karampekos, Georgios; Viazis, Nikos; Lahat, Adi; Ungar, Bella; Eliakim, Rami; Kuperstein, Rafael; Kriger-Sharabi, Ofra; Reiss-Mintz, Hilla; Yanai, Henit; Dotan, Iris; Zittan, Eran; Maharshak, Nitsan; Hirsch, Ayal; Weitman, Michal; Mantzaris, Gerassimos J.; Kopylov, Uri (June 9, 2023). "Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial". Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association: S1542–3565(23)00445–7. doi:10.1016/j.cgh.2023.05.023. PMID 37302449 Check
|pmid=value (help) – via PubMed.
This article "Nir Salomon" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Nir Salomon. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
